Detalhe da pesquisa
1.
Motive and Opportunity: MYC rearrangements in high-grade B-cell lymphoma with MYC and BCL2 rearrangements-an LLMPP study.
Blood
; 2024 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38701426
2.
DNMT3A mutations define a unique biological and prognostic subgroup associated with cytotoxic T cells in PTCL-NOS.
Blood
; 140(11): 1278-1290, 2022 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35639959
3.
A multiprotein supercomplex controlling oncogenic signalling in lymphoma.
Nature
; 560(7718): 387-391, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29925955
4.
Molecular classification and identification of an aggressive signature in low-grade B-cell lymphomas.
Hematol Oncol
; 41(4): 644-654, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37254453
5.
Distinct molecular profile of IRF4-rearranged large B-cell lymphoma.
Blood
; 135(4): 274-286, 2020 01 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-31738823
6.
EBV-positive HIV-associated diffuse large B cell lymphomas are characterized by JAK/STAT (STAT3) pathway mutations and unique clinicopathologic features.
Br J Haematol
; 194(5): 870-878, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34272731
7.
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma.
N Engl J Med
; 378(15): 1396-1407, 2018 04 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29641966
8.
Serum levels of TARC, MDC, IL-10, and soluble CD163 in Hodgkin lymphoma: a SWOG S0816 correlative study.
Blood
; 133(16): 1762-1765, 2019 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30723079
9.
Genomic alterations important for the prognosis in patients with follicular lymphoma treated in SWOG study S0016.
Blood
; 133(1): 81-93, 2019 01 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30446494
10.
Five-year follow-up of SWOG S0816: limitations and values of a PET-adapted approach with stage III/IV Hodgkin lymphoma.
Blood
; 134(15): 1238-1246, 2019 10 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31331918
11.
Reproducing the molecular subclassification of peripheral T-cell lymphoma-NOS by immunohistochemistry.
Blood
; 134(24): 2159-2170, 2019 12 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31562134
12.
Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma.
Blood
; 133(15): 1664-1676, 2019 04 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30782609
13.
MAPK and JAK-STAT pathways dysregulation in plasmablastic lymphoma.
Haematologica
; 106(10): 2682-2693, 2021 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33951889
14.
Molecular classification of primary mediastinal large B-cell lymphoma using routinely available tissue specimens.
Blood
; 132(22): 2401-2405, 2018 11 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-30257882
15.
A gene signature that distinguishes conventional and leukemic nonnodal mantle cell lymphoma helps predict outcome.
Blood
; 132(4): 413-422, 2018 07 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-29769262
16.
Loss of signalling via Gα13 in germinal centre B-cell-derived lymphoma.
Nature
; 516(7530): 254-8, 2014 Dec 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-25274307
17.
Enhanced DNA repair and genomic stability identify a novel HIV-related diffuse large B-cell lymphoma signature.
Int J Cancer
; 145(11): 3078-3088, 2019 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31044434
18.
Validation of the MCL35 gene expression proliferation assay in randomized trials of the European Mantle Cell Lymphoma Network.
Br J Haematol
; 184(4): 616-624, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30095158
19.
Next-generation ALK inhibitors are highly active in ALK-positive large B-cell lymphoma.
Blood
; 140(16): 1822-1826, 2022 10 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35802834
20.
Adult high-grade B-cell lymphoma with Burkitt lymphoma signature: genomic features and potential therapeutic targets.
Blood
; 130(16): 1819-1831, 2017 10 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-28801451